J Thorac Cardiovasc Surg 2008;136:241-242
© 2008 The American Association for Thoracic Surgery
Factors predicting poor survival after resection of stage IA non–small cell lung cancer
Laura Paleari, PhDa,
Patrizia Russo, PhDa,
Alfredo Cesario, MD, PhDb,c,
Pierluigi Granone, MD, PhDb
a Lung Cancer Unit, National Cancer Research Institute, Genoa, Italy
b Surgical Pathology Unit, Catholic University, Rome, Italy
c Respiratory Unit, IRCCS "San Raffaele", Rome, Italy
| The first 20% of the full text of this article appears below. |
To the Editor:
We have read with interest the paper by Chang and associates.1
Interestingly, we observe that the factors considered to predict poor survival after resection of stage IA non–small cell lung cancer (NSCLC) still remain tumor size, gender, age, and extent of resection.
It is true, in fact, that lung cancer staging currently rests on histopathologic and clinical criteria that have only limited power to predict relapse and survival. A major effort to improve the control of NSCLC entails the use of molecular profiling to characterize tumors and provide accurate predictions of the outcome after standard or novel treatments. Moreover, molecular profiling, as we2
already discussed . . . [Full Text of this Article]
Copyright © 2008 by The American Association for Thoracic Surgery.